Detalhe da pesquisa
1.
CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2.
PLoS One
; 18(7): e0288486, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450510
2.
The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine.
Vaccines (Basel)
; 10(4)2022 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35455285